Screener
DexCom DXCM EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by DexCom in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: DexCom’s 8-K, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 4:03 PM EDT
- Accession
- 0001093557-26-000142
FAQ
- What is DexCom's EPS (diluted)?
- DexCom (DXCM) reported EPS (diluted) of $0.64 in Q2 2026.
- How has DexCom's EPS (diluted) changed year-over-year?
- DexCom's EPS (diluted) increased by 42.2% year-over-year, from $0.45 to $0.64.
- What is the long-term trend for DexCom's EPS (diluted)?
- Over 3 years (2022 to 2025), DexCom's EPS (diluted) has grown at a 37.2% compound annual growth rate (CAGR), from $0.81 to $2.09.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about DexCom's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude